Clinical translation for endometrial cancer stem cells hypothesis (Q38557171)

4 September 2017

1 reference

title

Clinical translation for endometrial cancer stem cells hypothesis (English)

1 reference

4 September 2017

neoplastic stem cells

1 reference

1 reference

Mafalda Laranjo

2

0 references

Ana Margarida Abrantes

object named as

Ana Margarida Abrantes

3

0 references

Maria Filomena Botelho

object named as

Maria Filomena Botelho

5

0 references

author name string

Maria João Carvalho

1

1 reference

4 September 2017

Isabel Torgal

4

1 reference

4 September 2017

Carlos Freire Oliveira

6

1 reference

4 September 2017

30 July 2015

1 reference

Cancer and Metastasis Reviews

4 September 2017

1 reference

4 September 2017

34

1 reference

4 September 2017

401-416

1 reference

4 September 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s10555-015-9574-0

4 September 2017

0 references

cites work

Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Endometrial cancer: a review and current management strategies: part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Endometrial carcinoma in high-risk populations: is it time to consider a screening policy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Trends in corpus uteri cancer mortality in member states of the European Union.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Classification of endometrial carcinoma: more than two types

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Estrogen-progestin replacement therapy and endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Cigarette smoking and the risk of endometrial cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Endometrial thickness measurement for detecting endometrial cancer in women with postmenopausal bleeding: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Two pathogenetic types of endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Updates in diagnostic immunohistochemistry in endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Molecular bases of endometrial cancer: new roles for new actors in the diagnosis and the therapy of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Does high-grade endometrioid carcinoma (grade 3 FIGO) belong to type I or type II endometrial cancer? A clinical-pathological and immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Abnormalities of E- and P-cadherin and catenin (β-, γ-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Endometrial Glandular Dysplasia with Frequent p53 Gene Mutation: A Genetic Evidence Supporting Its Precancer Nature for Endometrial Serous Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Integrated genomic characterization of endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Adult stem cells in the endometrium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Hormone and growth factor signaling in endometrial renewal: role of stem/progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Tissue injury and repair in the female human reproductive tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Elucidating endometrial function in the post-genomic era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Clonogenicity of human endometrial epithelial and stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Characterization of side-population cells in human normal endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Identification of label-retaining cells in mouse endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Increased expression of the adult stem cell marker Musashi-1 in endometriosis and endometrial carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

The cancer stem cell hypothesis: a guide to potential molecular targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

The increasing complexity of the cancer stem cell paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

A cancer stem cell origin for human endometrial carcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Understanding cancer stem cell heterogeneity and plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Breast cancer stem cells: tools and models to rely on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Identification and expansion of the tumorigenic lung cancer stem cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Normal and cancer stem cells of the human female reproductive system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Uterine carcinosarcoma is derived from a single stem cell: an in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Evidence for cancer stem cells in human endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Functional analyses of the cancer stem cell-like properties of human endometrial tumor initiating cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Endometrial cancer side-population cells show prominent migration and have a potential to differentiate into the mesenchymal cell lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Isolation of side population cells from endometrial cancer cells using a violet laser diode

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

The adult stem cell marker Musashi-1 modulates endometrial carcinoma cell cycle progression and apoptosis via Notch-1 and p21WAF1/CIP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Expression of the stem cell marker, Nanog, in human endometrial adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Reprogramming of human somatic cells to pluripotency with defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Up-regulation of microRNA-145 promotes differentiation by repressing OCT4 in human endometrial adenocarcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Increased epithelial stem cell traits in advanced endometrial endometrioid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Epithelial-to-mesenchymal transition and stem cells in endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Stem cells in human endometrium and endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

The inhibitory effect of salinomycin on the proliferation, migration and invasion of human endometrial cancer stem-like cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Counting human somatic cell replications: methylation mirrors endometrial stem cell divisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Linc-RNA-RoR acts as a "sponge" against mediation of the differentiation of endometrial cancer stem cells by microRNA-145.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

MicroRNA-134 suppresses endometrial cancer stem cells by targeting POGLUT1 and Notch pathway proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

SALL4 is a new target in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Transcriptional Regulation of Aldehyde Dehydrogenase 1A1 Gene by Alternative Spliced Forms of Nuclear Factor Y in Tumorigenic Population of Endometrial Adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

CD133: molecule of the moment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Prognostic impact of CD133 expression as a tumor-initiating cell marker in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Endometrial cancer: a review and current management strategies: part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Human ATP-binding cassette (ABC) transporter family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Aldehyde dehydrogenases in cellular responses to oxidative/electrophilic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

A distinct "side population" of cells with high drug efflux capacity in human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Tumour stem cells and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Androgen receptor increases CD133 expression and progenitor-like population that associate with cisplatin resistance in endometrial cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Emerging therapeutic targets in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

Sodium butyrate inhibits the self-renewal capacity of endometrial tumor side-population cells by inducing a DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9574-0

10.1007/S10555-015-9574-0

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

4 September 2017

1024246716

0 references

Fatcat ID

release_24l6kcbb75dvhohyhlbskps7xe

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/24l6kcbb75dvhohyhlbskps7xe

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference